Otsuka Holdings
4578.T
#775
Rank
A$45.32 B
Marketcap
A$85.81
Share price
-0.12%
Change (1 day)
3.32%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: A$1.51 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are A$14.47 Billion. In 2023 the company made an earning of A$1.51 Billion a decrease over its 2022 earnings that were of A$1.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023A$1.51 B-20.93%
2022A$1.91 B-12.7%
2021A$2.19 B-19.92%
2020A$2.73 B13.9%
2019A$2.40 B52.07%
2018A$1.58 B11.22%
2017A$1.42 B-36.03%
2016A$2.22 B31.15%
2015A$1.69 B
2013A$3.51 B33.52%
2012A$2.63 B-4.65%
2011A$2.76 B45.53%
2010A$1.89 B